Skip to content
Screener

Geron GERN Gross product revenue — Total revenues

Other product segments

Chargebacks
-$9.19M
Distributor service fees
-$2.37M
Government rebates
-$1.97M-329%
Sales returns and allowances
-$1.43M-177%

Similar metrics at other companies

Kinetik Holdings logo
KNTKProduct revenue — Total revenues
$312.23M-0.1%
Quanterix Corporation logo
QTRXProduct revenue — Total revenues
$23.48M+39.5%
Cactus logo
WHDProduct revenue — Total revenues
$297.24M+42.2%
Exelixis logo
EXELGross product revenues — Total revenues
$812.78M+9.1%
Rhythm Pharmaceuticals, Inc. logo
RYTMProduct revenue, net — Total revenues
$60.11M+59.4%
Ardelyx logo
ARDXProduct supply revenue — Total revenues
$1.98M-68.1%

Other financials

Income statement

See full
Revenue$57.5M+17.2%
Operating income-$12.5M-0.3%
Net income-$16.7M-1.9%
EPS (diluted)-$0.020.0%

Balance sheet

See full
Cash & equivalents$64.5M-18.9%
Total debt$134.1M-0.3%
Total equity$218.6M-15.8%
Total assets$519.0M-6.5%

Cash flow

See full
Operating cash flow-$15.8M+42.3%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$1.01B+13.8%
Enterprise value$1.08B+14.5%
P/S4.9×-180×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-28.3%-2.3pp
Debt / equity0.6×+0.1×
Current ratio6.9×-1.0×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Geron’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:41 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000886744-26-000037
(in thousands)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Gross product revenue$72,436$57,874$137,789$103,186
Gross-to-net adjustments:
Chargebacks(9,190)(5,940)(17,354)(10,111)
Distributor service fees(2,371)(1,950)(4,540)(3,476)
Government rebates(1,969)(459)(3,627)(525)
Sales returns and allowances(1,433)(518)(3,024)(631)
Total gross-to-net adjustments(14,963)(8,867)(28,545)(14,743)
Net product revenue$57,473$49,007$109,244$88,443

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Geron's gross product revenue — total revenues?
Geron (GERN) reported gross product revenue — total revenues of $72.44M in Q2 2026.
How has Geron's gross product revenue — total revenues changed year-over-year?
Geron's gross product revenue — total revenues increased by 25.2% year-over-year, from $57.87M to $72.44M.
What does gross product revenue — total revenues mean?
This metric represents the total gross revenue generated from the sale of pharmaceutical products before accounting for deductions such as rebates, discounts, returns, and allowances. It serves as a primary indicator of the underlying market demand and commercial adoption of the company's therapeutic offerings. By isolating gross figures, investors can assess the total top-line value created by product sales prior to the impact of contractual pricing adjustments.

Ask your AI about Geron's gross product revenue — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude